Mechanism underlying the antioxidant activity of taurine: prevention of mitochondrial oxidant production

An important function of the β-amino acid, taurine, is the regulation of oxidative stress. However, taurine is neither a classical scavenger nor a regulator of the antioxidative defenses, leaving uncertain the mechanism underlying the antioxidant activity of taurine. In the present study, the taurine antagonist and taurine transport inhibitor, β-alanine, was used to examine the mechanism underlying the antioxidant activity of taurine. Exposure of isolated cardiomyocytes to medium containing β-alanine for a period of 48 h led to a 45% decrease in taurine content and an increase in mitochondrial oxidative stress, as evidenced by enhanced superoxide generation, the inactivation of the oxidant sensitive enzyme, aconitase, and the oxidation of glutathione. Associated with the increase in oxidative stress was a decline in electron transport activity, with the activities of respiratory chain complexes I and III declining 50–65% and oxygen consumption falling 30%. A reduction in respiratory chain activity coupled with an increase in oxidative stress is commonly caused by the development of a bottleneck in electron transport that leads to the diversion of electrons from the respiratory chain to the acceptor oxygen forming in the process superoxide. Because β-alanine exposure significantly reduces the levels of respiratory chain complex subunits, ND5 and ND6, the bottleneck in electron transport appears to be caused by impaired synthesis of key subunits of the electron transport chain complexes. Co-administration of taurine with β-alanine largely prevents the mitochondrial effects of β-alanine, but treatment of the cells with 5 mM taurine in the absence of β-alanine has no effect on the mitochondria, likely because taurine treatment has little effect on cellular taurine levels. Thus, taurine serves as a regulator of mitochondrial protein synthesis, thereby enhancing electron transport chain activity and protecting the mitochondria against excessive superoxide generation.

[1]  M. Seeliger,et al.  Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  J. Azuma,et al.  Why is taurine cytoprotective? , 2003, Advances in experimental medicine and biology.

[3]  M. Ikawa,et al.  Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy. , 2008, Journal of molecular and cellular cardiology.

[4]  A. Halestrap,et al.  The mitochondrial permeability transition pore - from molecular mechanism to reperfusion injury and cardioprotection , 2007 .

[5]  D. Kakhniashvili,et al.  Beneficial effect of taurine depletion on osmotic sodium and calcium loading during chemical hypoxia. , 2002, American journal of physiology. Cell physiology.

[6]  H. T. ter Keurs,et al.  Taurine depletion and excitation-contraction coupling in rat myocardium. , 1994, Circulation research.

[7]  Takehiro Yasukawa,et al.  Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R. Olson,et al.  Taurine deficiency and doxorubicin: interaction with the cardiac sarcolemmal calcium pump. , 1990, Biochemical pharmacology.

[9]  M. Armstrong,et al.  Taurine: an essential nutrient for the cat. , 1978, The Journal of nutrition.

[10]  Charles L. Hoppel,et al.  Production of Reactive Oxygen Species by Mitochondria , 2003, Journal of Biological Chemistry.

[11]  J. Azuma,et al.  Apoptotic cascade initiated by angiotensin II in neonatal cardiomyocytes: role of DNA damage. , 2003, American journal of physiology. Heart and circulatory physiology.

[12]  J. Turrens Formation of Reactive Oxygen Species in Mitochondria , 2007 .

[13]  O. Aruoma,et al.  The antioxidant action of taurine, hypotaurine and their metabolic precursors. , 1988, The Biochemical journal.

[14]  J. Azuma,et al.  Taurine-deficient cardiomyopathy: role of phospholipids, calcium and osmotic stress. , 2000, Advances in experimental medicine and biology.

[15]  B. Reusens,et al.  Is taurine a functional nutrient? , 2006, Current opinion in clinical nutrition and metabolic care.

[16]  Jang-Yen Wu,et al.  Role of taurine in the central nervous system , 2010, Journal of Biomedical Science.

[17]  J. G. Morris,et al.  Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy. , 1987, Science.

[18]  R J Huxtable,et al.  Physiological actions of taurine. , 1992, Physiological reviews.

[19]  D. Schaffer,et al.  Mitochondrial DNA damage triggers mitochondrial-superoxide generation and apoptosis. , 2008, American journal of physiology. Cell physiology.

[20]  G. Gaull Taurine as a conditionally essential nutrient in man. , 1986, Journal of the American College of Nutrition.

[21]  Takashi Ito,et al.  Effect of β-alanine treatment on mitochondrial taurine level and 5-taurinomethyluridine content , 2010, Journal of Biomedical Science.

[22]  J. Azuma,et al.  Physiological roles of taurine in heart and muscle , 2010, Journal of Biomedical Science.

[23]  J. Azuma,et al.  Possible Cause of Taurine-deficient Cardiomyopathy: Potentiation of Angiotensin II Action , 2003, Journal of cardiovascular pharmacology.

[24]  J. Sturman Taurine in development. , 1993, Physiological reviews.